Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Predictive modeling of COPD exacerbation rates using baseline risk factors.
Journal: Therapeutic advances in respiratory disease
Published: July 11, 2022
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 14, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study.
Journal: Respiratory medicine
Published: February 07, 2022
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.
Journal: American journal of respiratory and critical care medicine
Published: October 21, 2021
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial.
Journal: Therapeutic advances in respiratory disease
Published: August 25, 2021
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: August 02, 2021
Perplexing mortality data from triple therapy trials in COPD - Author's reply.
Journal: The Lancet. Respiratory medicine
Published: July 06, 2021
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Journal: Respiratory research
Published: April 07, 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 01, 2021
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Journal: Respiratory research
Published: March 24, 2021
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Journal: Respiratory medicine
Published: March 24, 2021
Last Updated: 09/26/2026